Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Celecoxib: Not So Harmless?

Created on 23 Aug 2026

Authors

Ousmane Kaba, Bouchra Chahboun, Maman Idi Chazali, Houssam Bkiyar, Brahim Housni

Published in

Cureus. Volume 18. Issue 7. Pages e113247. Epub Jul 23, 2026.

Abstract

Toxic epidermal necrolysis (TEN) is a severe and potentially fatal cutaneous reaction secondary to the use of drugs, including celecoxib. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is widely prescribed to relieve arthralgia because of its better gastrointestinal tolerance. However, it may also be responsible for skin reactions, most of which are benign. Serious cutaneous adverse reactions have been reported in the form of acute generalized exanthematous pustulosis (AGEP). TEN secondary to celecoxib is poorly documented. Discontinuation of the suspected or causative drug(s), transfer of the patient to a specialist unit as quickly as possible, and supportive care are the cornerstones of patient management.

PMID:
42633333
Bibliographic data and abstract were imported from PubMed on 23 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement